Texas Permanent School Fund Regeneron Pharmaceuticals, Inc. Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$883.2 - $1071.19 $3.77 Million - $4.57 Million	-4,270 Reduced 19.55%	17,576 $18.5 Million
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $253,655 - $279,131	-281 Reduced 1.27%	21,846 $21 Million
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $49,611 - $56,428	64 Added 0.29%	22,127 $19.4 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $394,004 - $480,446	-569 Reduced 2.51%	22,063 $18.2 Million
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $153,306 - $181,846	219 Added 0.98%	22,632 $16.3 Million
Q1 2023 May 01, 2023	BUY	$680.49 - $826.97 $4.9 Million - $5.95 Million	7,198 Added 47.31%	22,413 $18.4 Million
Q4 2022 Feb 07, 2023	BUY	$705.89 - $766.39 $33,882 - $36,786	48 Added 0.32%	15,215 $11 Million
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $515,999 - $651,163	899 Added 6.3%	15,167 $10.4 Million
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $233,597 - $314,745	426 Added 3.08%	14,268 $8.43 Million
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $428,486 - $502,869	-720 Reduced 4.94%	13,842 $9.67 Million
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $911,415 - $1.13 Million	-1,677 Reduced 10.33%	14,562 $9.2 Million
Q3 2021 Oct 28, 2021	SELL	$574.03 - $680.96 $662,430 - $785,827	-1,154 Reduced 6.63%	16,239 $9.83 Million
Q2 2021 Jul 27, 2021	SELL	$472.8 - $558.54 $88,886 - $105,005	-188 Reduced 1.07%	17,393 $9.72 Million
Q1 2021 May 03, 2021	SELL	$446.73 - $548.2 $405,184 - $497,217	-907 Reduced 4.91%	17,581 $8.32 Million
Q4 2020 Feb 04, 2021	SELL	$478.3 - $607.98 $555,784 - $706,472	-1,162 Reduced 5.91%	18,488 $8.93 Million
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $1.02 Million - $1.23 Million	1,876 Added 10.55%	19,650 $11 Million
Q2 2020 Aug 04, 2020	BUY	$493.32 - $643.92 $1.62 Million - $2.12 Million	3,287 Added 22.69%	17,774 $11.1 Million
Q1 2020 Apr 27, 2020	BUY	$336.18 - $494.43 $118,335 - $174,039	352 Added 2.49%	14,487 $7.07 Million
Q4 2019 Feb 03, 2020	SELL	$274.13 - $376.51 $205,323 - $282,005	-749 Reduced 5.03%	14,135 $5.31 Million
Q3 2019 Oct 31, 2019	SELL	$273.46 - $318.39 $77,115 - $89,785	-282 Reduced 1.86%	14,884 $4.13 Million
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $24,567 - $34,015	-82 Reduced 0.54%	15,166 $4.75 Million
Q1 2019 May 02, 2019	SELL	$372.08 - $439.57 $135,437 - $160,003	-364 Reduced 2.33%	15,248 $6.26 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $598,767 - $718,620	-1,783 Reduced 10.25%	15,612 $5.83 Million
Q3 2018 Oct 22, 2018	SELL	$351.14 - $408.51 $518,984 - $603,777	-1,478 Reduced 7.83%	17,395 $7.03 Million
Q2 2018 Jul 23, 2018	SELL	$284.6 - $344.99 $307,368 - $372,589	-1,080 Reduced 5.41%	18,873 $6.51 Million
Q1 2018 Apr 20, 2018	SELL	$315.82 - $393.78 $340,138 - $424,101	-1,077 Reduced 5.12%	19,953 $6.87 Million
Q4 2017 Jan 23, 2018	SELL	$358.63 - $469.95 $93,602 - $122,656	-261 Reduced 1.23%	21,030 $7.91 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $9.18 Million - $10.7 Million	21,291	21,291 $9.52 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account